Blog

Prescription skincare is the most natural telehealth vertical for a wellness brand that already has an audience: visual results, cash-pay pricing, creator-native acquisition, and a 90-day refill rhythm that compounds. The clinical spine is photo-based async review, which means the whole program rides on the quality of the pictures your intake collects. Here is the launch playbook: the photo spec, the entry SKUs, the pharmacy decision, and the expansion path.

Weight loss is crowded, hair loss is saturated, and ED is a knife fight against national brands. Meanwhile twelve real niches still combine durable demand, thin competition, and workable unit economics. Here is each one with its demand signal, competition density, economics sketch, regulatory lift, and time to launch, plus one honest line about who should not pick it.

Skip the guru math. Public filings and published prices are the only benchmark sources that cannot lie to you. Hims guided Q2 to $680-700M of revenue with $35-55M of adjusted EBITDA, manufacturers set cash price floors from $149 to $449, and Rock Health counted $7.4B of H1 funding with a $14M median deal. Here is what those numbers actually imply for your pricing, marketing, and retention math, and what they cannot tell a 500-patient brand.

Reddit is roughly 47 percent of Perplexity's citations, and every major assistant leans on it when a patient asks whether a health brand is legitimate. Your patients research there, your future B2B customers research there, and most telehealth brands are either invisible on the platform or getting banned from it. Here is how to participate in a way that survives moderators, compliance review, and the AI answer layer built on top.

TRT is one of the most durable subscription categories in DTC telehealth: a symptomatic patient, a measurable biomarker, and a treatment that works best when it never lapses. It is also one of the most demanding builds, because testosterone is a Schedule III controlled substance and the labs are not optional. Here is the operator's playbook: the lab cadence, the compliance clock, the $100-200 per month bundle economics, and the retention loop that makes the category worth building.

Q2 prints are landing all week: Hims & Hers reported Monday after close, with LifeMD, Teladoc, Omada, and the rest of the cohort in the same window. We built this frame on what was confirmed going in, the guidance, the disclosed pivots, the channel data, so it holds whatever the actuals say. Five structural takeaways, plus a setup table designed for swapping the actuals in as transcripts land.

Between September and November, millions of Americans learn what their 2027 health plan will and will not cover, and this year's employer surveys guarantee more coverage surprises than any cycle in memory. Each surprise sends a household searching for alternatives the same week. DTC brands that prepare for open enrollment the way retail prepares for the holidays, content indexed early, funnels tuned for coverage refugees, billing ready for HSA dollars, will harvest a demand season their competitors treat as background noise. The plan starts now.

The 2026 citation data is out, and it reshapes the AI-visibility playbook: institutional sources dominate health answers, the major engines barely overlap in what they cite, community content carries startling weight, and freshness compounds everything. For health brands, the naive play, outrank the institutions, is dead on arrival. The winning play is precision: knowing which questions brands can own, which engine rewards what, and how to publish for each. Here is the data-driven edition.

The operators who built on compounded GLP-1 volume are redesigning their businesses this year, and the strongest redesigns share a shape: not a pivot to a different single bet, but diversification into a portfolio of care verticals running on one operating layer. Here are the playbooks, which verticals pair well, what each addition actually costs on modular infrastructure, and the sequencing that keeps quality intact.

A new patient cohort formed this year: people who would never book an injection consult but will absolutely start a conversation about a daily pill. They arrive brand-aware, comparison-minded, and earlier in their decision than the classic GLP-1 lead. Serving them takes a different funnel: education-forward, comparison-honest, and designed for a longer consideration arc. Here is the design.

Retail health changed its strategy this summer. Instead of building clinics, the giants are assembling marketplaces and hiring telehealth veterans to run them, which means they need supply: credible, specialized care brands ready to plug in. For niche telehealth operators, that flips the retail story from threat to distribution channel. Here is what marketplace-ready actually means and how to become it.

New employer survey data confirmed what operators started noticing this spring: instead of expanding GLP-1 coverage, a growing share of large employers are steering employees toward DTC telehealth platforms and HSA dollars. That is a named, measurable demand channel flowing directly at cash-pay brands, and it rewards the operators who build a soft landing for the handed-off patient. Here is how to catch it.

Health brands that built their growth engine inside ad platforms spent 2026 discovering how little of it they owned. The winning response is not louder complaints about signal loss; it is ownership. First-party conversion infrastructure, owned intake funnels, server-side events, consented data, and CRM-driven lifecycle, turns measurement into an asset the brand controls and makes every acquisition channel work better at once.

Midlife women's health is the most energetic new-brand vertical in telehealth right now, and it is still early. Tens of millions of women are underserved on menopause care, the clinical playbook has matured, and modern infrastructure lets a focused team launch a serious program in weeks. This is the founder-side blueprint: the patient, the program architecture, the provider model, the launch sequence, and the retention engine for a brand built to last.

Most DTC telehealth brands are built entirely around consumer acquisition. The fastest-growing opportunity in 2026 is the channel they are not using: employers and health savings accounts. Benefit plans want GLP-1 and chronic-care programs, HSA enrollment is opening up, and the brands that build a B2B2C offering on top of their existing clinical infrastructure unlock a large, durable, lower-CAC growth lever.

A DTC telehealth funnel in 2026 is a precise, end-to-end operating system. It runs from the first ad impression to the second-year refill, with every step measurable, optimizable, and increasingly automated. This is the complete operator's anatomy: nine stages, what happens in each, where each stage breaks, what good looks like, and how the modern telehealth platform supports the whole journey.

A meaningful majority of GLP-1 intake traffic is mobile, and most intake forms were designed desktop-first and shrunk down. Mobile-first intake design is a different discipline. The patterns that lift completion on the phone are specific, well-tested, and almost always improve the desktop experience too. This is the operator's playbook.

Trust signals on the landing page do not automatically transfer into the intake form. The intake is where the patient decides whether to share health data, upload photos, and pay. Smart trust signal placement inside the form, done at the right micro-moments, lifts completion without slowing the patient down. This is the operator's placement playbook.

GLP-1 advertising in 2026 has moved into its grown-up phase. Real founders, real clinicians, real patient stories, calm clinical aesthetics, and care-narrative positioning are outperforming the loud creative of earlier cohorts. The channel mix is broader. The funnel is deeper. The work is more rewarding. This is what is winning right now.

Patients are increasingly starting healthcare research in ChatGPT, Claude, and Perplexity instead of Google. Generative Engine Optimization is the discipline of getting your DTC telehealth brand cited as the answer when an LLM responds. The playbook is part SEO, part structured data, part facts that AI can actually quote.